CytoDyn Inc. (OTCMKTS:CYDY – Get Free Report)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.24 and traded as low as $0.20. CytoDyn shares last traded at $0.20, with a volume of 1,025,437 shares.
CytoDyn Price Performance
The company has a fifty day simple moving average of $0.24 and a 200-day simple moving average of $0.18. The company has a market cap of $251.42 million, a P/E ratio of -20.40 and a beta of 1.33.
About CytoDyn
CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.
Featured Articles
- Five stocks we like better than CytoDyn
- What is the S&P/TSX Index?
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- How to Profit From Value Investing
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- The Role Economic Reports Play in a Successful Investment Strategy
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for CytoDyn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytoDyn and related companies with MarketBeat.com's FREE daily email newsletter.
